Similar Papers

Paper Title
Journal
Date
Author
Hematopoietic Progenitor Cell (HPC) Collection Is Feasible in Previously Transplanted Multiple Myeloma Patients and Plerixafor Improves Collection
Xenofon Papanikolaou ... Michele Cottler-Fox
Blood | VOL. 120
Xenofon Papanikolaou, et. al.Xenofon Papanikolaou ... Michele Cottler-Fox
16 Nov 2012
A novel hematopoietic progenitor cell mobilization regimen, utilizing bortezomib and filgrastim, for patients undergoing autologous transplant.
Sunil Abhyankar ... Joseph Mcguirk
Journal of clinical apheresis | VOL. 31
Sunil Abhyankar, et. al.Sunil Abhyankar ... Joseph Mcguirk
04 Mar 2016
Validation of simple prediction algorithms to consistently achieve CD3+ and postselection CD34+ targets with leukapheresis.
Edward J Yoon ... Joel A Brochstein
Transfusion | VOL. 60
Edward J Yoon, et. al.Edward J Yoon ... Joel A Brochstein
22 Nov 2019
Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilization
F Bertolini ... G Robustelli Della Cuna
Annals of Oncology | VOL. 9
F Bertolini, et. al.F Bertolini ... G Robustelli Della Cuna
01 Aug 1998
View more papers

More From: Transfusion

Paper Title
Journal
Date
Author
Use of an anti-D-alloimmunization kinetics model to correct the interval censored D-alloimmunization rate following red blood cell transfusions.
Emil Ainsworth Jochumsen ... Mark H Yazer
Transfusion | VOL. -
Emil Ainsworth Jochumsen, et. al.Emil Ainsworth Jochumsen ... Mark H Yazer
05 Feb 2025
Comparison of whole blood versus red blood cells and plasma to correct trauma-induced coagulopathy ex vivo.
Andrea Rossetto ... Ross Davenport
Transfusion | VOL. -
Andrea Rossetto, et. al.Andrea Rossetto ... Ross Davenport
05 Feb 2025
An updated assessment of low titer O whole blood use in the Trauma Quality Improvement Program registry.
Steven G Schauer ... Mark H Yazer
Transfusion | VOL. -
Steven G Schauer, et. al.Steven G Schauer ... Mark H Yazer
05 Feb 2025
An in silico simulation of the frequency of administering HLA-incompatible low titer group O whole blood units when the donor pool includes unscreened female donors.
Mark H Yazer ... Jansen N Seheult
Transfusion | VOL. -
Mark H Yazer, et. al.Mark H Yazer ... Jansen N Seheult
05 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.